CTRI/2020/12/029965Not yet recruiting未知
Investigating the role of nicotinic neuromodulation in levodopa-induced dyskinesias â?? a multimodal study.
ational Brain Research Centre0 sites0 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- 未知
- Status
- Not yet recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •non-smoker ( >10 years)
- •- able to provide informed consent
Exclusion Criteria
- •The subjects may not be eligible to participate if he/she -
- •-Has any neurological disorder (except PD in the patient group)
- •-Has a current depressive episode, schizophrenia or bipolar disorder (self-declared and screened with GHQ-12 (Goldberg et al., 1978; Qin et al., 2018))
- •-Has had any head injury with loss of consciousness
- •- Has had any seizures in the past
- •-Has cognitive impairment (Mini Mental Status Examination (MMSE) test score <25)
- •-Abuses drugs/alcohol
- •-Is pregnant or nursing
- •Subjects will not be eligible for MRI scanning if they -
- •-Have non-MRI compatible metal in the body such as a cardiac pacemaker, brain stimulator, surgical metal, cochlear implants, artificial heart valves or dental implants.
- •-Are unable to lie flat on the back for the duration of the scan.
- •-Have uncontrollable head movements.
- •-Are claustrophobic.
- •Subjects will not be eligible to undergo TMS if they â??
- •-Have metal implants in the body such as brain stimulator, surgical metal, cochlear implants, cardiac pacemaker, intracardiac lines, implanted pumps or stimulators.
Investigators
Similar Trials
Completed
Phase 1
Neurobiology of Nicotine and Non-nicotine Components of Tobacco AddictionSmokingNCT01056926Duke University147
Completed
Not Applicable
Effects of nicotinergic receptor stimulation with vareniclin on focal and non-focal plasticity in schizophrenia patientsF20SchizophreniaDRKS00013735Klinik für Psychiatrie und Psychotherapie- Klinikum der Universität München61
Completed
Phase 1
Effect of Nicotine on Brain Reward PathwaysDepressive DisorderNCT02346539Mclean Hospital46
Completed
Phase 4
Systems neuropharmacology of nicotine in aversive learning in humansHealthy subjectsDRKS00025233Institut für Systemische Neurowissenschaften88
Recruiting
Unknown
Evaluation of the effects of nicotineamide mononucleotide administered intravenously to healthy subjects.healthy subjectsJPRN-UMIN000049123TOKYO GINZA WELLNESS & AGING CLINIC20
